BRKR Earnings & Financial Statements
Bruker Corporation
$60.33
-$2.08(-3.33%)
53
Overall
40
Value
66
Tech
55
Quality
Market Cap
$9.38B
Volume
1.51M
52W Range
$32.37 - $68.98
Target Price
$67.77
BRKR earnings and financial statements: Bruker Corporation's income statement, balance sheet and cash flow statement, annual and quarterly.
BRKR Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $3.44B | $3.37B | $2.96B | $2.53B | $2.42B |
| Cost of revenue | $1.86B | $1.72B | $1.45B | $1.23B | $1.21B |
| Operating income | $236.00M | $253.10M | $436.90M | $432.70M | $413.30M |
| EBITDA | $302.60M | $436.90M | $677.50M | $519.80M | $498.00M |
| Net income | -$8.60M | $113.10M | $427.20M | $296.60M | $277.10M |
| EPS (diluted) | $-0.15 | $0.76 | $2.90 | $1.99 | $1.81 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $6.24B | $5.81B | $4.25B | $3.61B | $3.65B |
| Total liabilities | $3.73B | $3.99B | $2.84B | $2.48B | $2.57B |
| Shareholders’ equity | $2.46B | $1.78B | $1.38B | $1.11B | $1.07B |
| Cash and equivalents | $298.80M | $183.40M | $488.30M | $645.50M | $1.07B |
| Long-term debt | $1.99B | $2.18B | $1.24B | $1.24B | $1.26B |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $134.10M | $251.30M | $350.10M | $274.40M | $282.40M |
| Capital expenditure | -$120.20M | -$115.30M | -$106.90M | -$129.20M | -$92.00M |
| Free cash flow | $13.90M | $136.00M | $243.20M | $145.20M | $190.40M |
| Dividends paid | $32.90M | $30.20M | $29.40M | $29.80M | $24.20M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BRKR | $60.33 | -3.3% | 1.51M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |